Originally published by our sister publication Specialty Pharmacy Continuum
By Myles Starr
The CDC has tracked an increase in hepatitis C virus (HCV) cases over the past decade, but efforts to reduce infections are failing to meet their targets. Data presented at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans, outline how pharmacist-led programs can help increase detection and treatment of HCV infections (poster 4-051).
“Acute HCV infection continues to rise (in